Delivery Order SPE2DE24D0013-SPE2D625F3RMY

The U.S. Defense Department's Medical Supply Chain awarded a $2,960 firm fixed-price delivery order to Cepheid Inc. on September 17, 2025, with an ultimate completion date of September 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits for infectious diseases, will perform the work at its California headquarters. This award carries no set-aside designation and represents a continuation of Cepheid's established role as a primary supplier of diagnostic testing capabilities to the Department of Defense and other federal healthcare agencies.

This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts, which provide the framework for ongoing procurement of molecular diagnostic solutions. Cepheid maintains substantial IDV agreements with the Department of Veterans Affairs, including a $32.8 million contract with VA Veterans Integrated Service Network 6 for diagnostic system reagents and assays through September 2030, and a $2.5 million contract with VISN 21 for polymerase chain reaction testing for laboratory microbiology. These vehicles enable the company to support critical diagnostic testing needs across federal healthcare systems for conditions including COVID-19, influenza, RSV, and other infectious diseases. The relatively modest value of this specific delivery order reflects the routine procurement activities typical under larger master agreements.